TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT03290508

Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.
“There is sufficient follow-up data to meet the endpoints of the study.”

The sponsor’s own words in the registry.

Life of this trial

2017201820192020202120222023Started2017-09-14Registered2017-09-19Stopped2022-01-14

Vital statistics

Status
Terminated
Sponsor
Myriad Genetic Laboratories, Inc.
Sponsor type
Industry
Conditions
Prostate Cancer
Interventions
Prolaris Testing
Participants
524
Sites
34
Countries
United States

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.